463 related articles for article (PubMed ID: 10639013)
1. Effects of nitric oxide and prostacyclin on deformability and aggregability of red blood cells of rats ex vivo and in vitro.
Starzyk D; Korbut R; Gryglewski RJ
J Physiol Pharmacol; 1999 Dec; 50(4):629-37. PubMed ID: 10639013
[TBL] [Abstract][Full Text] [Related]
2. Endothelial secretogogues and deformability of erythrocytes.
Korbut RA; Adamek-Guzik T; Madej J; Korbut R
J Physiol Pharmacol; 2002 Dec; 53(4 Pt 1):655-65. PubMed ID: 12512700
[TBL] [Abstract][Full Text] [Related]
3. The effect of prostacyclin and nitric oxide on deformability of red blood cells in septic shock in rats.
Korbut R; Gryglewski RJ
J Physiol Pharmacol; 1996 Dec; 47(4):591-9. PubMed ID: 9116326
[TBL] [Abstract][Full Text] [Related]
4. Secretory dysfunction of vascular endothelium limits the effect of angiotensin converting enzyme inhibitor quinapril on aggregation of erythrocytes in experimental hypertension.
Korbut RA; Madej J; Adamek-Guzik T; Korbut R
J Physiol Pharmacol; 2003 Sep; 54(3):397-408. PubMed ID: 14566078
[TBL] [Abstract][Full Text] [Related]
5. [The effect of aspirin on rheological properties of erythrocytes in essential hypertension].
Korbut RA; Adamek-Guzik T
Przegl Lek; 2002; 59(2):71-5. PubMed ID: 12152252
[TBL] [Abstract][Full Text] [Related]
6. The role of nitric oxide in regulation of deformability of red blood cells in acute phase of endotoxaemia in rats.
Starzyk D; Korbut R; Gryglewski RJ
J Physiol Pharmacol; 1997 Dec; 48(4):731-5. PubMed ID: 9444620
[TBL] [Abstract][Full Text] [Related]
7. Reduced red cell deformability associated with blood flow and platelet activation: improved by dipyridamole alone or combined with aspirin.
Bozzo J; Hernández MR; Ordinas A
Cardiovasc Res; 1995 Nov; 30(5):725-30. PubMed ID: 8595619
[TBL] [Abstract][Full Text] [Related]
8. Red blood cell rheological alterations in hypertension induced by chronic inhibition of nitric oxide synthesis in rats.
Bor-Küçükatay M; Yalçin O; Gökalp O; Kipmen-Korgun D; Yesilkaya A; Baykal A; Ispir M; Senturk UK; Kaputlu I; Başkurt OK
Clin Hemorheol Microcirc; 2000; 22(4):267-75. PubMed ID: 11081464
[TBL] [Abstract][Full Text] [Related]
9. The in vivo antioxidant effectiveness of alpha-tocopherol in oxidative stress induced by sodium nitroprusside in rat red blood cells.
Yerer MB; Aydogan S
Clin Hemorheol Microcirc; 2004; 30(3-4):323-9. PubMed ID: 15258362
[TBL] [Abstract][Full Text] [Related]
10. On the mechanism of thrombogenesis during pharmacological thrombolysis.
Korbut R; Gryglewski RJ
Pol J Pharmacol; 1996; 48(1):85-8. PubMed ID: 9112633
[TBL] [Abstract][Full Text] [Related]
11. Extra- and intracellular signaling pathways under red blood cell aggregation and deformability changes.
Muravyov AV; Tikhomirova IA; Maimistova AA; Bulaeva SV
Clin Hemorheol Microcirc; 2009; 43(3):223-32. PubMed ID: 19923692
[TBL] [Abstract][Full Text] [Related]
12. Modulation of density-fractionated RBC deformability by nitric oxide.
Bor-Kucukatay M; Meiselman HJ; Başkurt OK
Clin Hemorheol Microcirc; 2005; 33(4):363-7. PubMed ID: 16317245
[TBL] [Abstract][Full Text] [Related]
13. Protection of erythrocytes from sub-hemolytic mechanical damage by nitric oxide mediated inhibition of potassium leakage.
Baskurt OK; Uyuklu M; Meiselman HJ
Biorheology; 2004; 41(2):79-89. PubMed ID: 15090678
[TBL] [Abstract][Full Text] [Related]
14. Interaction of antiplatelet drugs in vitro: aspirin, iloprost, and the nitric oxide donors SIN-1 and sodium nitroprusside.
Negrescu EV; Grünberg B; Kratzer MA; Lorenz R; Siess W
Cardiovasc Drugs Ther; 1995 Aug; 9(4):619-29. PubMed ID: 8547213
[TBL] [Abstract][Full Text] [Related]
15. Lipid peroxidation and deformability of red blood cells in experimental sepsis in rats: The protective effects of melatonin.
Yerer MB; Yapislar H; Aydogan S; Yalcin O; Baskurt O
Clin Hemorheol Microcirc; 2004; 30(2):77-82. PubMed ID: 15004332
[TBL] [Abstract][Full Text] [Related]
16. Streptokinase-prostacyclin--nitric oxide: in vivo interactions.
Gryglewski RJ; Swies J
Adv Prostaglandin Thromboxane Leukot Res; 1995; 23():479-84. PubMed ID: 7537438
[No Abstract] [Full Text] [Related]
17. Nitric oxide-mediated cyclooxygenase activation. A key event in the antiplatelet effects of nitrovasodilators.
Salvemini D; Currie MG; Mollace V
J Clin Invest; 1996 Jun; 97(11):2562-8. PubMed ID: 8647949
[TBL] [Abstract][Full Text] [Related]
18. Synergistic platelet antiaggregatory effects of the adenylate cyclase activator iloprost and the guanylate cyclase activating agent SIN-1 in vivo.
Spiecker M; Darius H; Meyer J
Thromb Res; 1993 Jun; 70(5):405-15. PubMed ID: 7690993
[TBL] [Abstract][Full Text] [Related]
19. Antithrombotic effects of KP-10614, a novel and stable prostacyclin (PGI2) analog.
Kanayama T; Kimura Y; Iseki K; Hayashi Y; Tamao Y; Mizogami S
J Pharmacol Exp Ther; 1990 Dec; 255(3):1210-7. PubMed ID: 1702154
[TBL] [Abstract][Full Text] [Related]
20. [Disturbances in aggregability of red blood cells in essential hypertension].
Korbut RA; Adamek-Guzik T
Folia Med Cracov; 2005; 46(1-2):3-19. PubMed ID: 17037284
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
